IN THE HEADLINES:




Investigations - Ketek

What is Ketek?
Ketek was formally approved by the FDA on April 1, 2004, after two previous application rejections in 2001 and 2003. Ketek was approved for the treatment of respiratory infections including sinusitis, bronchitis, and pneumonia. Ketek is a ketolide antibiotic.

What are the medical and legal issues with Ketek?
A confidential FDA Ketek memo has become public; the report reveals twelve cases of liver failure including four deaths associated with antibiotic medication Ketek (generic: telithromycin).

The Wall Street Journal reported about the memo, but the FDA is not releasing it publicly. New concerns have been raised about Ketek’s liver risks, and a strong black box warning may be placed on Ketek’s label.

In January 2006, Dr. John Hanson, who works in the liver transplant center at Carolinas Medical Center, reported three cases of liver toxicity in three patients taking Ketek. One took Ketek for only five days and ultimately died from liver failure. Another underwent a liver transplant, and the third eventually recovered from hepatitis.

Do you have a potential claim?
Our office is currently investigating potential claims regarding side effects from the use of Ketek. If you or a loved one was prescribed Ketek and has suffered any of the side effects listed above, please contact one of our Indiana Class Action lawyers to discuss your potential claim.